S&P 500   4,590.43 (+1.15%)
DOW   35,246.95 (+1.93%)
QQQ   383.58 (+0.12%)
AAPL   165.93 (+2.53%)
MSFT   322.49 (-0.16%)
FB   314.70 (+2.56%)
GOOGL   2,838.86 (-0.04%)
AMZN   3,421.98 (+0.95%)
TSLA   979.12 (-3.53%)
NVDA   292.88 (-4.58%)
BABA   120.44 (+7.57%)
NIO   31.82 (-1.03%)
CGC   9.93 (-0.60%)
AMD   135.90 (-5.63%)
GE   96.58 (+4.11%)
MU   81.92 (+0.37%)
T   23.54 (+0.34%)
F   19.20 (+0.31%)
DIS   150.16 (+2.69%)
PFE   52.32 (-3.59%)
AMC   28.59 (-1.45%)
ACB   5.86 (+0.69%)
BA   205.68 (+3.62%)
S&P 500   4,590.43 (+1.15%)
DOW   35,246.95 (+1.93%)
QQQ   383.58 (+0.12%)
AAPL   165.93 (+2.53%)
MSFT   322.49 (-0.16%)
FB   314.70 (+2.56%)
GOOGL   2,838.86 (-0.04%)
AMZN   3,421.98 (+0.95%)
TSLA   979.12 (-3.53%)
NVDA   292.88 (-4.58%)
BABA   120.44 (+7.57%)
NIO   31.82 (-1.03%)
CGC   9.93 (-0.60%)
AMD   135.90 (-5.63%)
GE   96.58 (+4.11%)
MU   81.92 (+0.37%)
T   23.54 (+0.34%)
F   19.20 (+0.31%)
DIS   150.16 (+2.69%)
PFE   52.32 (-3.59%)
AMC   28.59 (-1.45%)
ACB   5.86 (+0.69%)
BA   205.68 (+3.62%)
S&P 500   4,590.43 (+1.15%)
DOW   35,246.95 (+1.93%)
QQQ   383.58 (+0.12%)
AAPL   165.93 (+2.53%)
MSFT   322.49 (-0.16%)
FB   314.70 (+2.56%)
GOOGL   2,838.86 (-0.04%)
AMZN   3,421.98 (+0.95%)
TSLA   979.12 (-3.53%)
NVDA   292.88 (-4.58%)
BABA   120.44 (+7.57%)
NIO   31.82 (-1.03%)
CGC   9.93 (-0.60%)
AMD   135.90 (-5.63%)
GE   96.58 (+4.11%)
MU   81.92 (+0.37%)
T   23.54 (+0.34%)
F   19.20 (+0.31%)
DIS   150.16 (+2.69%)
PFE   52.32 (-3.59%)
AMC   28.59 (-1.45%)
ACB   5.86 (+0.69%)
BA   205.68 (+3.62%)
S&P 500   4,590.43 (+1.15%)
DOW   35,246.95 (+1.93%)
QQQ   383.58 (+0.12%)
AAPL   165.93 (+2.53%)
MSFT   322.49 (-0.16%)
FB   314.70 (+2.56%)
GOOGL   2,838.86 (-0.04%)
AMZN   3,421.98 (+0.95%)
TSLA   979.12 (-3.53%)
NVDA   292.88 (-4.58%)
BABA   120.44 (+7.57%)
NIO   31.82 (-1.03%)
CGC   9.93 (-0.60%)
AMD   135.90 (-5.63%)
GE   96.58 (+4.11%)
MU   81.92 (+0.37%)
T   23.54 (+0.34%)
F   19.20 (+0.31%)
DIS   150.16 (+2.69%)
PFE   52.32 (-3.59%)
AMC   28.59 (-1.45%)
ACB   5.86 (+0.69%)
BA   205.68 (+3.62%)
OTC:AKBLF

ALK-Abello A/S Stock Forecast, Price & News

$469.00
0.00 (0.00%)
(As of 12/3/2021 12:00 AM ET)
Add
Compare
Today's Range
$469.00
$469.00
50-Day Range
N/A
52-Week Range
$382.00
$487.00
Volume
N/A
Average Volume
100 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive AKBLF News and Ratings via Email

Sign-up to receive the latest news and ratings for ALK-Abello A/S and its competitors with MarketBeat's FREE daily newsletter.


About ALK-Abello A/S

ALK-Abello A/S engages in the production and development of pharmaceutical products to prevent and treat allergies. It also manufactures tablet-based allergy vaccines for pollen, house dust mites, animals, and insect stings. Its treatment comprises allergy vaccines, emergency treatment, and allergy diagnostics. The company was founded by Poul Christian Krejner Tejn Barfod on June 9, 1923 and is headquartered in Horsholm, Denmark.

Headlines

ALK-Abello A/S (OTC:AKBLF) Downgraded by DNB Markets
November 12, 2021 |  americanbankingnews.com
See More Headlines

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Optionable
Not Optionable

MarketRank

Overall MarketRank

0.00 out of 5 stars

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












ALK-Abello A/S (OTC:AKBLF) Frequently Asked Questions

Is ALK-Abello A/S a buy right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ALK-Abello A/S in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" ALK-Abello A/S stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AKBLF, but not buy additional shares or sell existing shares.
View analyst ratings for ALK-Abello A/S
or view top-rated stocks.

What is ALK-Abello A/S's stock symbol?

ALK-Abello A/S trades on the OTC under the ticker symbol "AKBLF."

How do I buy shares of ALK-Abello A/S?

Shares of AKBLF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ALK-Abello A/S's stock price today?

One share of AKBLF stock can currently be purchased for approximately $469.00.

What is ALK-Abello A/S's official website?

The official website for ALK-Abello A/S is www.alk.net.

Where are ALK-Abello A/S's headquarters?

ALK-Abello A/S is headquartered at Bøge Allé 6-8, Hørsholm, Capital Region.

How can I contact ALK-Abello A/S?

ALK-Abello A/S's mailing address is Bøge Allé 6-8, Hørsholm, Capital Region. The company can be reached via phone at 45.45.74.75.76.


This page was last updated on 12/6/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.